SCHEMBL26229754

SCHEMBL26229754

CC(C)C(=O)Nc1ncnn2c([C@@H]3O[C@](C)(COC(=O)C(C)C)[C@@H](OC(=O)C(C)C)[C@H]3OC(=O)C(C)C)ccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23818693 0.87 — —
SCHEMBL26337340 0.87 — —
SCHEMBL25387899 0.87 TMPRSS2 (0.34) —
SCHEMBL26230756 0.86 POLRMT (0.39) —
SCHEMBL23818950 0.86 — —
SCHEMBL26344794 0.84 — —
SCHEMBL26334199 0.82 BTN3A1 (0.39) —
SCHEMBL26826974 0.81 — —
SCHEMBL26229867 0.80 POLRMT (0.35) —
SCHEMBL26240578 0.80 GRM5 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023168194-A1 ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. (US) 2023-09-07 — — WO disclosed
Send feedback